Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Calgary

$54,836.00

Stem cell heterogeneity and cell fate decision

EF 2011-12

Résumé
Stem cells are multi-potent because they can develop into the various cell types of the human body, such as red blood cells, nerve cells, skin cells etc. With multi-potency comes the question of choice of cell fate: How do stem cells decide which cell type to commit to? An answer is not only of fundamental biological interest but also of eminent practical importance since we have yet to learn how to efficiently steer stem cells into the desired direction if we are to exploit them for therapy. Each cell contains the same 25,000 genes but a ""genetic network"" permits only the activation of distinct subsets of genes at a time, generating ""gene expression patterns"" which specify the cell type. The current picture that a stem cell becomes a red blood cell because a signal, such as the hormone Epo, instructs it how to change its gene expression pattern to that of the red blood cell is oversimplified. Our latest studies in blood cells suggest that every stem cell, even within a clonal cell population, has its own individuality: The stem cell's gene expression fluctuates randomly between various patterns, giving rise to heterogeneity of cells in a clonal population of apparently identical stem cells. Some of these short-lived patterns surprisingly resemble that of one of the stem cell's prospective cell fate as if individual cells independently vacillate between patterns hinting at future cell types. An external signal then only acts ""to push through the final fate decision"". Thus, if in fact only a small fraction of cells responds at a given moment to a specific fate-determining signal this would explain the notorious inefficiency in attempts to convert stem cells into a desired cell type. Our project will apply these new insights from blood stem cells to embryonic stem cells which face a much larger variety of fate choices. Using latest technologies that will allow us to measure gene expression patterns in individual cells we will learn more about the dynamics of gene pattern fluctuations. We will also examine whether variations of chromatin that package the DNA are the source of role in the fluctuations. Understanding the source of stem cell heterogeneity and its link to fate decision is paramount for harnessing the developmental potential of stem cells for therapy.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
372012-2009
Name nom
Huang, Sui
Department département
Biological Sciences
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
54836
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Partie
3
Nb partie
3
Application title
Stem cell heterogeneity and cell fate decision
Keyword
NSERC
Application summary
Stem cells are multi-potent because they can develop into the various cell types of the human body, such as red blood cells, nerve cells, skin cells etc. With multi-potency comes the question of choice of cell fate: How do stem cells decide which cell type to commit to? An answer is not only of fundamental biological interest but also of eminent practical importance since we have yet to learn how to efficiently steer stem cells into the desired direction if we are to exploit them for therapy. Each cell contains the same 25,000 genes but a ""genetic network"" permits only the activation of distinct subsets of genes at a time, generating ""gene expression patterns"" which specify the cell type. The current picture that a stem cell becomes a red blood cell because a signal, such as the hormone Epo, instructs it how to change its gene expression pattern to that of the red blood cell is oversimplified. Our latest studies in blood cells suggest that every stem cell, even within a clonal cell population, has its own individuality: The stem cell's gene expression fluctuates randomly between various patterns, giving rise to heterogeneity of cells in a clonal population of apparently identical stem cells. Some of these short-lived patterns surprisingly resemble that of one of the stem cell's prospective cell fate as if individual cells independently vacillate between patterns hinting at future cell types. An external signal then only acts ""to push through the final fate decision"". Thus, if in fact only a small fraction of cells responds at a given moment to a specific fate-determining signal this would explain the notorious inefficiency in attempts to convert stem cells into a desired cell type. Our project will apply these new insights from blood stem cells to embryonic stem cells which face a much larger variety of fate choices. Using latest technologies that will allow us to measure gene expression patterns in individual cells we will learn more about the dynamics of gene pattern fluctuations. We will also examine whether variations of chromatin that package the DNA are the source of role in the fluctuations. Understanding the source of stem cell heterogeneity and its link to fate decision is paramount for harnessing the developmental potential of stem cells for therapy.